Showing results (351-360 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|July 22, 2015
Carboplatin/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trialY J He, S J Winham, J M Hoskins, et al.
The Pharmacogenomics Journal|June 10, 2015
Genetic risk of subsequent esophageal cancer in lymphoma and breast cancer long-term survival patients: a pilot studyE Boldrin, E Rumiato, M Fassan, et al.
The Pharmacogenomics Journal|August 17, 2016
HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactionsY Yang, S Chen, F Yang, et al.
The Pharmacogenomics Journal|January 21, 2018
Construction of full-length Japanese reference panel of class I HLA genes with single-molecule, real-time sequencingTakahiro Mimori, Jun Yasuda, Yoko Kuroki, et al.
The Pharmacogenomics Journal|December 29, 2017
Influence of BCL2L11 polymorphism on osteonecrosis during treatment of childhood acute lymphoblastic leukemiaMaria Plesa, Vincent Gagné, Sanja Glisovic, et al.
The Pharmacogenomics Journal|March 10, 2018
A 6-week laboratory research rotation in pharmacogenomics: a model for preparing pharmacy students to practice precision medicinePrema S Rao, Ryan Endicott, Randy Mullins, et al.
The Pharmacogenomics Journal|March 10, 2018
Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudyYu Wu, Yilun Zhou, Yuesong Pan, et al.
The Pharmacogenomics Journal|November 22, 2017
Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipientsW S Oetting, B Wu, D P Schladt, et al.
The Pharmacogenomics Journal|November 22, 2017
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomesS Allegra, J Cusato, S De Francia, et al.
The Pharmacogenomics Journal|March 28, 2007
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patchS P David, M R Munafò, M F G Murphy, et al.
Pageof 135